[
    [
        {
            "time": "",
            "original_text": "调研回录|健帆生物（300529.SZ）：衡阳本次地方集采对公司影响很小 预判短期不会被纳入全国性集中带量采购范围",
            "features": {
                "keywords": [
                    "健帆生物",
                    "地方集采",
                    "全国性集采",
                    "影响很小"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "调研回录|健帆生物（300529.SZ）：衡阳本次地方集采对公司影响很小 预判短期不会被纳入全国性集中带量采购范围",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "健帆生物聘任外籍高管 大力开拓海外市场",
            "features": {
                "keywords": [
                    "健帆生物",
                    "外籍高管",
                    "海外市场",
                    "开拓"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物聘任外籍高管 大力开拓海外市场",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "子女买入公司股票后六个月内卖出 健帆生物董事会主席收警示函 金融监管处罚",
            "features": {
                "keywords": [
                    "健帆生物",
                    "董事会主席",
                    "警示函",
                    "金融监管",
                    "处罚"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "子女买入公司股票后六个月内卖出 健帆生物董事会主席收警示函 金融监管处罚",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "健帆生物：聘任Caroline Xiaoku Jin为副总经理",
            "features": {
                "keywords": [
                    "健帆生物",
                    "Caroline Xiaoku Jin",
                    "副总经理",
                    "聘任"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物：聘任Caroline Xiaoku Jin为副总经理",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)聘任Caroline Xiaoku Jin为副总经理",
            "features": {
                "keywords": [
                    "健帆生物",
                    "Caroline Xiaoku Jin",
                    "副总经理",
                    "聘任"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)聘任Caroline Xiaoku Jin为副总经理",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "健帆生物监事会主席彭小红收警示函 子女违法减持 董监高成员异常事件",
            "features": {
                "keywords": [
                    "健帆生物",
                    "监事会主席",
                    "彭小红",
                    "警示函",
                    "违法减持",
                    "董监高成员"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物监事会主席彭小红收警示函 子女违法减持 董监高成员异常事件",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]